Overview

High Dose Methylprednisolone Verses Low Dose in Correction of Congenital Acynotic Heart Disease

Status:
Recruiting
Trial end date:
2022-01-30
Target enrollment:
Participant gender:
Summary
To compare the effect of low dose methylprednisolone versus high dose on inflammatory mediators' level and cardioprotective effect after CPB in correction of congenital acyanotic heart disease.
Phase:
Phase 4
Details
Lead Sponsor:
Ain Shams University
Treatments:
Methylprednisolone
Methylprednisolone Acetate
Methylprednisolone Hemisuccinate
Prednisolone
Prednisolone acetate
Prednisolone hemisuccinate
Prednisolone phosphate